These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 39268267)
1. Pan-Cancer Analysis Confirms the Prognostic and Immunological Implications of the 1,25-Dihydroxy Vitamin D3 Receptor in Cervical Squamous Cell Carcinoma. Faris IFM; Ibrahim N; Zeanelabdeen TS; Alfaki M Cureus; 2024 Aug; 16(8):e66743. PubMed ID: 39268267 [TBL] [Abstract][Full Text] [Related]
2. [Pan-cancer analysis of ubiquitin-specific protease 7 and its expression changes in the carcinogenesis of scar ulcer]. Zhang SY; Ruan JJ; Jin DM; Chen N; Xie WG; Ruan QF Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jun; 39(6):518-526. PubMed ID: 37805766 [No Abstract] [Full Text] [Related]
3. CCND1 as a Prognostic and Diagnostic Biomarker and the Impact of Its Epigenetic Alterations on Cancer Survival. Taha MY; Mohamed NO; Alhaj LG; Altayeb I; Basheer A; Idrees S; Said AM; Alfaki M Cureus; 2024 Jul; 16(7):e65504. PubMed ID: 39188436 [TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures. Zhang X; Wang Y; A G; Qu C; Chen J Front Immunol; 2021; 12():721030. PubMed ID: 34531868 [TBL] [Abstract][Full Text] [Related]
5. Distinct Roles of Adenosine Deaminase Isoenzymes ADA1 and ADA2: A Pan-Cancer Analysis. Gao ZW; Yang L; Liu C; Wang X; Guo WT; Zhang HZ; Dong K Front Immunol; 2022; 13():903461. PubMed ID: 35663977 [TBL] [Abstract][Full Text] [Related]
6. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across multiple cancers. Wang N; Zhu L; Wang L; Shen Z; Huang X Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736 [TBL] [Abstract][Full Text] [Related]
7. Pan-cancer and single-cell analysis reveal dual roles of lymphocyte activation gene-3 (LAG3) in cancer immunity and prognosis. Wang Y; Zhao Y; Zhang G; Lin Y; Fan C; Wei H; Chen S; Guan L; Liu K; Yu S; Fu L; Zhang J; Yuan Y; He J; Cai H Sci Rep; 2024 Oct; 14(1):24203. PubMed ID: 39406840 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatic Analysis Reveals Bone Marrow Kinase as a Potential Diagnostic and Prognostic Biomarker for Multiple Cancer Types. Khalafallah SA; Eltayeb Ahmed EA; Elnour LS; Mohammed R; Makawi A; Mohamed AK; Balla A; Alamin MF; Alfaki M Cureus; 2024 Aug; 16(8):e68093. PubMed ID: 39347140 [TBL] [Abstract][Full Text] [Related]
9. Pan-cancer analysis of HS6ST2: associations with prognosis, tumor immunity, and drug resistance. Huang L; Irshad S; Sultana U; Ali S; Jamil A; Zubair A; Sultan R; Abdel-Maksoud MA; Mubarak A; Almunqedhi BM; Almanaa TN; Malik A; Alamri A; Kodous AS; Mares M; Zaky MY; Saba Sajjad S; Hameed Y Am J Transl Res; 2024; 16(3):873-888. PubMed ID: 38586106 [TBL] [Abstract][Full Text] [Related]
10. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis. Wu C; Ma C; Yuan J; Zhou P Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296 [TBL] [Abstract][Full Text] [Related]
11. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer. Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191 [TBL] [Abstract][Full Text] [Related]
12. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas. Zhao S; Li Y; Xu J; Shen L Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705 [TBL] [Abstract][Full Text] [Related]
13. Identifies microtubule-binding protein Wang W; Zhang J; Wang Y; Xu Y; Zhang S Comput Struct Biotechnol J; 2022; 20():3322-3335. PubMed ID: 35832625 [TBL] [Abstract][Full Text] [Related]
14. The molecular feature of macrophages in tumor immune microenvironment of glioma patients. Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502 [TBL] [Abstract][Full Text] [Related]
15. Acetyl Coenzyme A Synthase 2 Acts as a Prognostic Biomarker Associated with Immune Infiltration in Cervical Squamous Cell Carcinoma. Li CJ; Chiu YH; Chang C; Chang YI; Sheu JJ; Chiang AJ Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34206705 [TBL] [Abstract][Full Text] [Related]
16. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts. Zeng Z; Gao Y; Li J; Zhang G; Sun S; Wu Q; Gong Y; Xie C Comput Struct Biotechnol J; 2022; 20():496-507. PubMed ID: 35070171 [TBL] [Abstract][Full Text] [Related]
17. Decreased expression of CLCA2 and the correlating with immune infiltrates in patients with cervical squamous cell carcinoma: A bioinformatics analysis. Yang X; Cao JL; Yang FN; Li XF; Tao LM; Wang F Taiwan J Obstet Gynecol; 2021 May; 60(3):480-486. PubMed ID: 33966732 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of tumor necrosis factor-α-inducible protein 8-like 2 (TIPE2): A potential novel pan-cancer immune checkpoint. Bai KH; Zhang YY; Li XP; Tian XP; Pan MM; Wang DW; Dai YJ Comput Struct Biotechnol J; 2022; 20():5226-5234. PubMed ID: 36187930 [TBL] [Abstract][Full Text] [Related]
19. Exploration of a Robust and Prognostic Immune Related Gene Signature for Cervical Squamous Cell Carcinoma. Zuo Z; Xiong J; Zeng C; Jiang Y; Xiong K; Tao H; Guo Y Front Mol Biosci; 2021; 8():625470. PubMed ID: 33748188 [No Abstract] [Full Text] [Related]
20. Functional analysis of tumor-derived immunoglobulin lambda and its interacting proteins in cervical cancer. Wang J; Huang J; Ding H; Ma J; Zhong H; Wang F; Chen Y; Peng H BMC Cancer; 2023 Oct; 23(1):929. PubMed ID: 37784026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]